OM t of c.iii - Vision Research Coordinating Center - Washington ...
OM t of c.iii - Vision Research Coordinating Center - Washington ...
OM t of c.iii - Vision Research Coordinating Center - Washington ...
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
2/22/96 Chapter 3 Entry and Enrollment page 3-1<br />
3.1 Screening for Eligibility<br />
Chapter 3<br />
Entry and Enrollment<br />
Screening for CLEK Study eligibility is conducted on any patient who carries the<br />
working diagnosis <strong>of</strong> keratoconus or in whom keratoconus is a possible diagnosis.<br />
An Eligibility Form is completed by the Clinician on any keratoconus patient<br />
evaluated for CLEK Study eligibility at any visit to a Participating Clinic. Referring<br />
doctors can complete a draft Eligibility Form to evaluate a patient, but the Participating<br />
Clinic must complete its own Eligibility Form for submission to the <strong>Coordinating</strong><br />
<strong>Center</strong>. This will track non-eligible patients and eligible patients who decline to<br />
participate in the CLEK Study. The Eligibility Form is forwarded to the <strong>Coordinating</strong><br />
<strong>Center</strong>.<br />
3.2 Implementation <strong>of</strong> Eligibility Criteria<br />
Any patient carrying a working diagnosis <strong>of</strong> keratoconus is a CLEK Study<br />
candidate. Given the relative simplicity <strong>of</strong> a preliminary screening for the entry and<br />
exclusion criteria, patients can be quickly evaluated to determine whether it is worth the<br />
Study candidate’s and the Clinic’s time to schedule the Baseline Visit. The Clinician<br />
should complete the Eligibility Form on any patient carrying the working diagnosis <strong>of</strong><br />
keratoconus and should forward a copy <strong>of</strong> the form—whether the patient turns out to<br />
be eligible or not—to the <strong>Coordinating</strong> <strong>Center</strong>. If the patient appears eligible upon<br />
completion <strong>of</strong> the Eligibility Form, the Clinician explains the CLEK Study to the patient,<br />
requests that the patient sign an informed consent form, and schedules the patient for<br />
his or her Baseline Visit once the patient has provided informed consent.<br />
CLEK Participating Clinic personnel are informed at the beginning <strong>of</strong> the Study<br />
and at annual CLEK Study Group meetings that enrollment <strong>of</strong> an ineligible patient is a<br />
serious protocol error. The Participating Clinics will be reminded <strong>of</strong> the ramifications <strong>of</strong><br />
enrolling a patient who is later deemed ineligible. Corrective action will be taken<br />
against Clinics who repeatedly enroll ineligible patients.<br />
3.3 Inclusion Criteria<br />
If all <strong>of</strong> the following conditions are satisfied, the patient is eligible for the CLEK<br />
Study:<br />
• Age: At least 12 years old<br />
• Irregular corneal surface in either eye as determined by distortion <strong>of</strong> keratometric<br />
mires, <strong>of</strong> the retinoscopic reflex, or <strong>of</strong> the red reflex.